- £40.18m
- £44.58m
- £30.80m
- 20
- 38
- 11
- 10
REG - AIM - AIM Notice - 27/07/2023
AnnouncementREG - Creo Medical Group - Award of Shares under Share Incentive Plan
AnnouncementREG - AIM - AIM Notice - 12/07/2023
AnnouncementREG - Creo Medical Group - Issue of Equity and TVR
AnnouncementREG - Creo Medical Group - Result of AGM
AnnouncementREG - Creo Medical Group - AGM Statement & Directorate Succession Planning
AnnouncementREG - Creo Medical Group - First upper GI Speedboat procedure in Europe
AnnouncementRCS - Creo Medical Group - Appointment of Marco Scarci
AnnouncementREG - Creo Medical Group - Speedboat Inject upper GI clearance in Europe
AnnouncementREG - Creo Medical Group - Speedboat™ Inject selected by NICE for assessment
AnnouncementREG - Creo Medical Group - Posting of Annual Report and Notice of AGM
AnnouncementREG - Creo Medical Group - First in-human milestone for MicroBlate™ Flex
AnnouncementRCS - Creo Medical Group - Royal Oldham Hospital Agreement
AnnouncementRCS - Creo Medical Group - Attendance at Digestive Disease Week
AnnouncementREG - Creo Medical Group - Final Results
AnnouncementREG - Creo Medical Group - Albyn Medical earn out update
AnnouncementREG - Creo Medical Group - Total Voting Rights
AnnouncementRCS - Creo Medical Group - MicroBlate™ Flex clinical study
AnnouncementREG - Creo Medical Group - Director/PDMR and PCA Share Dealings
Announcement